Metoprolol Succinate Tablet, Film Coated, Extended Release
Product Images NDC 45963-709

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Metoprolol Succinate (NDC 45963-709). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Actavis Pharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

1 (Image 1)

1 (Image 1)
FDA Label Image

1 (Image 10)

1 (Image 10)
FDA Label Image

1 (Image 11)

1 (Image 11)
Label for Metoprolol Succinate Extended-Release Tablets USP 25 mg by Actavis Pharma, Inc. The label shows a 100-tablet quantity. It includes a barcode, dosage strength, and storage instructions, specifying controlled room temperature and child safety warnings.*
FDA Label Image

1 (Image 12)

1 (Image 12)
Label for Metoprolol Succinate Extended-Release Tablets USP 50 mg by Actavis Pharma, Inc. The film-coated tablet has 50 mg strength, with 100 tablets per package. The label includes dosage form and storage instructions, manufacturer information, and cautions to keep out of reach of children.*
FDA Label Image

1 (Image 13)

1 (Image 13)
Label for Metoprolol Succinate Extended-Release Tablets, USP 100 mg by Actavis Pharma, Inc. The tablet is film-coated and extended release. The label includes the NDC 45963-677-11 and indicates a package size of 100 tablets. Instructions on storage and dispensing are also visible, as well as a barcode and manufacturer details from Teva Pharmaceuticals USA, Inc.*
FDA Label Image

1 (Image 14)

1 (Image 14)
Label for Metoprolol Succinate Extended-Release Tablets, USP 200 mg by Actavis Pharma, Inc. The label states the product name, strength of 200 mg, dosage form as extended-release film-coated tablets, and packaging of 100 tablets. It includes storage instructions and a note that this is a drug for further processing labeled for prescription use only.*
FDA Label Image

1 (Image 2)

1 (Image 2)
Chemical structure of metoprolol succinate, showing the molecular arrangement of its atoms and bonds as depicted in the diagram.*
FDA Label Image

1 (Image 3)

1 (Image 3)
FDA Label Image

1 (Image 4)

1 (Image 4)
FDA Label Image

2 (Image 5)

2 (Image 5)
Chemical structure of metoprolol succinate, showing the molecular components including aromatic ring, ether groups, hydroxyl group, amine side chain, and succinate portion.*
FDA Label Image

1 (Image 6)

1 (Image 6)
A forest plot chart showing results for subgroups in MERIT-HF study with metoprolol succinate extended-release. It compares relative risk and 95% confidence intervals for total mortality, total mortality or all-cause hospitalization, and total mortality hospitalization for heart failure across various subgroups including geography, NYHA class, ejection fraction, etiology, sex, race, previous MI, diabetes, hypertension status, and heart rate categories.*
FDA Label Image

1 (Image 7)

1 (Image 7)
FDA Label Image

1 (Image 8)

1 (Image 8)
FDA Label Image

1 (Image 9)

1 (Image 9)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.